HSPA8 and plasma cell myeloma: For instance, miR-26b-5p inhibites cell proliferation and induces apoptosis in multiple myeloma cells by targeting JAG1, and maintains the stemness of hepatocellular carcinoma cells by inhibiting HSC71/HSPA8.